Opinion: Standardizing gene product nomenclature-a call to action
Proc Natl Acad Sci U S A
2021 Jan 19;118(3):e2025207118.
Elspeth A Bruford
Cynthe L Sims
Timothy J O'Leary
Anthony W I Lo
Nimesh R Patel
Keyur Pravinchandra Patel
Federico A Monzon
Alexis B Carter
Margaret L Gulley
Susan M Mockus
Thuy L Phung
Heather E Williams
Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215.
Department of Surgery, Kurume University, Kurume, Fukuoka 8300011, Japan.
HUGO Gene Nomenclature Committee (HGNC), EMBL-EBI, Wellcome Genome Campus, Hinxton, Cambridge CB10 1SD, UK; firstname.lastname@example.org.
Department of Haematology, University of Cambridge, Cambridge CB2 0XY, UK.
Department of Laboratory Medicine and Pathology, University of Minnesota Medical School, Minneapolis, MN 55455.
Torreyana Corp, San Diego, CA 92126.
Blackhawk Genomics, Concord, CA 94518.
Advagenix, Rockville, MD, 20850.
Office of Research and Development, Veterans Health Administration, Washington, DC 20420; email@example.com.
Department of Pathology, University of Maryland School of Medicine, Baltimore, MD 21201.
Molecular Pathology Laboratory, Division of Anatomical Pathology, Queen Mary Hospital, Hong Kong Special Administrative Region, People's Republic of China.
Department of Molecular Genetics, Quest Diagnostics, San Juan Capistrano, CA 92690.
Department of Pathology, Rhode Island Hospital and Alpert Medical School at Brown University, Providence, RI 02903.
Department of Hematopathology, The University of Texas MD Anderson Cancer Center, Houston, TX 77030.
Institute of Medical Immunology, Martin Luther University Halle-Wittenberg, Halle 06112, Germany.
Clinical and Translational Epidemiology Unit, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02215.
Division of Gastroenterology, Massachusetts General Hospital and Harvard Medical School, Boston, MA 02215.
Department of Nutrition, Harvard T.H. Chan School of Public Health, Boston, MA 02215.
Castle Biosciences, Friendswood, TX 77546.
Pathology and Laboratory Medicine, Children's Healthcare of Atlanta, Atlanta, GA 30322.
Department of Pathology, University of North Carolina, Chapel Hill, NC 27599.
Precision Biomarker Laboratories, Cedars-Sinai Medical Center, Los Angeles, CA 90048.
Department of Pathology, University of South Alabama, Mobile, AL 36617.
Department of Pathology and Molecular Medicine, Queen's University, Kingston, Ontario, K7L 3N6, Canada.
Molecular Diagnostics, Kingston Health Sciences Centre, Kingston, Ontario, K7L 2V7, Canada.
Cytogenetics Laboratory, Haematological Malignancy Diagnostic Centre, Viapath at King's College Hospital, London SE5 9RS, UK.
Department of Pathology and Cell Biology, Columbia University Irving Medical Center, New York, NY 10032.
Program in MPE Molecular Pathological Epidemiology, Department of Pathology, Brigham and Women's Hospital and Harvard Medical School, Boston, MA 02215; firstname.lastname@example.org.
Department of Epidemiology, Harvard T.H. Chan School of Public Health, Boston, MA 02115.
Cancer Immunology and Cancer Epidemiology Programs, Dana-Farber Harvard Cancer Center, Boston, MA 02115.
Broad Institute of Massachusetts Institute of Technology and Harvard, Cambridge, MA 02142.
No abstract available
Research Support, N.I.H., Extramural
Research Support, Non-U.S. Gov't
Proteins / classification*
Proteins / genetics
Proteins / standards
RNA / genetics*
Terminology as Topic*
R35 CA197735/CA/NCI NIH HHS/United States
R21 CA230873/CA/NCI NIH HHS/United States
R01 CA248857/CA/NCI NIH HHS/United States
R01 CA151993/CA/NCI NIH HHS/United States
U24 HG003345/HG/NHGRI NIH HHS/United States
WT_/Wellcome Trust/United Kingdom
208349/Z/17/Z/WT_/Wellcome Trust/United Kingdom